SilverArc Capital

Private Equity Boston, United States ·Founded 2020

Overview

SilverArc Capital is a private equity firm based in Boston, Massachusetts, focusing on healthcare investments. The firm engages in a wide range of investment stages, including seed, early stage, series A and B, growth, late stage, pre-IPO, buyout, turnaround, and distressed situations. Its portfolio spans multiple industries such as biotechnology, healthcare, health diagnostics, genetics, medical, pharmaceutical, therapeutics, and agriculture. SilverArc Capital's investment sizes typically range from $50 million to $100 million, reflecting its commitment to substantial healthcare ventures. The firm's investment strategy is characterized by a diversified approach, targeting companies at various stages of development and across multiple sectors within the healthcare industry. This broad focus allows SilverArc Capital to leverage opportunities in both emerging and established markets, aiming to drive growth and innovation in the healthcare sector. SilverArc Capital's portfolio includes investments in companies like Aardvark Therapeutics, a late-stage venture in health care and therapeutics, and Modulight Biotherapeutics, a biotechnology firm. These investments underscore the firm's dedication to advancing healthcare solutions through strategic partnerships and capital infusion.

Investment Focus

  • Focus on healthcare sector
  • Interest in various investment stages

Portfolio Companies

Aardvark TherapeuticsCongruence TherapeuticsModulight Biotherapeutics

Reach SilverArc Capital directly

Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.

Unlock full contacts →

Frequently asked questions about SilverArc Capital

What sectors does SilverArc Capital invest in?

SilverArc Capital invests in Healthcare, Agriculture, Biotechnology, Pharmaceutical, Therapeutics and Medical, and is based in Boston, United States. SilverArc Capital is listed as a private equity in the ConnectSafely investor database.

What stage does SilverArc Capital invest at?

SilverArc Capital backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage, writing cheques of 50M - 100M.

Which regions does SilverArc Capital invest in?

SilverArc Capital invests across United States, Canada, Germany and Israel.

Who are the partners at SilverArc Capital?

Team members listed for SilverArc Capital include Amanda Goodell (Chief Financial Officer) and Andrew Timpson (President & Chief Operating Officer).

What companies has SilverArc Capital invested in?

SilverArc Capital's portfolio includes Aardvark Therapeutics, Congruence Therapeutics and Modulight Biotherapeutics.

How do I contact SilverArc Capital?

SilverArc Capital's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.

Last updated · Source: ConnectSafely investor database